Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2020 2
2021 1
2022 2
2023 3
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Somatostatin Analogs in Clinical Practice: a Review.
Gomes-Porras M, Cárdenas-Salas J, Álvarez-Escolá C. Gomes-Porras M, et al. Among authors: cardenas salas j. Int J Mol Sci. 2020 Feb 29;21(5):1682. doi: 10.3390/ijms21051682. Int J Mol Sci. 2020. PMID: 32121432 Free PMC article. Review.
Real-world effectiveness and safety of oral semaglutide in people living with type 2 diabetes: A nationwide multicentre retrospective observational study (ENDO2 S-RWD).
Moreno-Pérez O, Reyes-Garcia R, Modrego-Pardo I, Doulatram-Gamgaram VK, Cases CC, Guillen-Morote C, Mendoza NA, Tejera-Pérez C, Cárdenas-Salas J, Martínez-Fuster S, Lardiés-Sánchez B, Márquez-Pardo R, Pinés P, Fernández-García JC; SEEN Diabetes Area. Moreno-Pérez O, et al. Among authors: cardenas salas j. Diabetes Obes Metab. 2024 Apr;26(4):1519-1523. doi: 10.1111/dom.15431. Epub 2023 Dec 27. Diabetes Obes Metab. 2024. PMID: 38151966 No abstract available.
Primary aldosteronism prevalence enhanced by strict adherence to 2016 Endocrine Society guidelines: insights from an endocrine hypertension unit.
Ruiz-Sanchez JG, Fernandez Sanchez Á, Cardenas-Salas J, Fernandez-Cagigao Y, Alegre Bellassai ER, Rossello MG, Fernandez-Fernandez B, Jimenez Moreno B, Paniagua A, Vazquez C, Meneses D. Ruiz-Sanchez JG, et al. Among authors: cardenas salas j. J Hypertens. 2024 Oct 1;42(10):1813-1822. doi: 10.1097/HJH.0000000000003822. Epub 2024 Jul 24. J Hypertens. 2024. PMID: 39196692
Long-term complete remission of metastatic adrenocortical carcinoma.
Cárdenas-Salas J, Castelo B, Regojo RM, González-Sanchez JA, Álvarez-Escolá C. Cárdenas-Salas J, et al. Horm Mol Biol Clin Investig. 2022 Sep 8;44(1):67-71. doi: 10.1515/hmbci-2022-0017. eCollection 2023 Mar 1. Horm Mol Biol Clin Investig. 2022. PMID: 36069780
Changes in Serum Creatinine Levels Can Help Distinguish Hypovolemic from Euvolemic Hyponatremia.
Ruiz-Sánchez JG, Cuesta M, Gómez-Hoyos E, Cárdenas-Salas J, Rubio-Herrera MÁ, Martínez-González E, De Miguel Novoa P, Ternero-Vega JE, Calle-Pascual AL, Runkle I. Ruiz-Sánchez JG, et al. Among authors: cardenas salas j. Medicina (Kaunas). 2022 Jun 25;58(7):851. doi: 10.3390/medicina58070851. Medicina (Kaunas). 2022. PMID: 35888570 Free PMC article.
About a rare case of hypoglycemia: Non-islet cell tumor hypoglycemia (NICTH).
Sierra-Poyatos R, Cárdenas-Salas J, Ortega-Juaristi M, Vázquez-Martínez C. Sierra-Poyatos R, et al. Among authors: cardenas salas j. Endocrinol Diabetes Nutr (Engl Ed). 2021 Oct;68(8):589-591. doi: 10.1016/j.endien.2021.11.008. Endocrinol Diabetes Nutr (Engl Ed). 2021. PMID: 34872643 No abstract available.
REAL life study of subcutaneous SEMaglutide in patients with type 2 diabetes in SPain: Ambispective, multicenter clinical study. Results in the GLP1-experienced cohort.
Cárdenas-Salas JJ, Sierra Poyatos RM, Luca BL, Sánchez Lechuga B, Modroño Móstoles N, Montoya Álvarez T, Gómez Montes MP, Ruiz Sánchez JG, Meneses González D, Sánchez-Lopez R, Casado Cases C, Pérez de Arenaza Pozo V, Vázquez Martínez C. Cárdenas-Salas JJ, et al. J Diabetes Complications. 2024 Dec;38(12):108874. doi: 10.1016/j.jdiacomp.2024.108874. Epub 2024 Sep 17. J Diabetes Complications. 2024. PMID: 39442257
Effectiveness and Tolerability of the Intensification of Canagliflozin Dose from 100 mg to 300 mg Daily in Patients with Type 2 Diabetes in Real Life: The INTENSIFY Study.
Gorgojo-Martinez JJ, Ferreira-Ocampo PJ, Galdón Sanz-Pastor A, Cárdenas-Salas J, Antón-Bravo T, Brito-Sanfiel M, Almodóvar-Ruiz F. Gorgojo-Martinez JJ, et al. Among authors: cardenas salas j. J Clin Med. 2023 Jun 25;12(13):4248. doi: 10.3390/jcm12134248. J Clin Med. 2023. PMID: 37445283 Free PMC article.
Potential of insulin deprescription adding a GLP-1 receptor agonist as a therapeutic strategy to improve the metabolic profiles of patients with type 2 diabetes mellitus.
Perez de Arenaza Pozo V, Cárdenas Salas J, Vázquez Martínez C. Perez de Arenaza Pozo V, et al. Among authors: cardenas salas j. Endocrinol Diabetes Nutr (Engl Ed). 2024 Nov;71(9):405-407. doi: 10.1016/j.endien.2024.11.007. Endocrinol Diabetes Nutr (Engl Ed). 2024. PMID: 39608966 No abstract available.
About a rare case of hypoglycemia: Non-islet cell tumor hypoglycemia (NICTH).
Sierra-Poyatos R, Cárdenas-Salas J, Ortega-Juaristi M, Vázquez-Martínez C. Sierra-Poyatos R, et al. Among authors: cardenas salas j. Endocrinol Diabetes Nutr (Engl Ed). 2020 Dec 10:S2530-0164(20)30220-2. doi: 10.1016/j.endinu.2020.07.008. Online ahead of print. Endocrinol Diabetes Nutr (Engl Ed). 2020. PMID: 33309586 English, Spanish. No abstract available.
12 results